Opus Genetics, Inc. (FRA:R3X1)
Germany
· Delayed Price · Currency is EUR 1.886
+0.120 (6.80%)
At close: Dec 4, 2025
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of €134.57 million as of December 5, 2025. Its market cap has increased by 394.53% in one year.
Market Cap
134.57M
Enterprise Value
109.00M
Revenue
12.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.89
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from 17.89M to 134.57M, an increase of 652.37%. That is a compound annual growth rate of 48.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 131.88M | 263.44% |
| Dec 31, 2024 | 36.29M | -41.14% |
| Dec 29, 2023 | 61.65M | -10.30% |
| Dec 30, 2022 | 68.73M | 21.12% |
| Dec 31, 2021 | 56.74M | -1.36% |
| Dec 31, 2020 | 57.52M | 221.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 181.89B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |